CVS Health Corporation is a U.S.-based multinational corporation operating in the healthcare sector, with a focus on the retail pharmacy, integrated healthcare services, and pharmacy benefits management segments. The company’s early structure is associated with Stanley Goldstein, Sidney Goldstein, and Ralph Hoagland, driven by the creation of a retail model centered on health and wellness products.
Its portfolio of products and services includes retail pharmacies, pharmacy benefits plans, clinical services, outpatient care, treatment management, and corporate healthcare solutions. Operations also encompass medical clinics, laboratories, telemedicine services, wellness programs, and pharmaceutical distribution.
Its market presence is primarily national, with operations in all U.S. states through retail units, clinical care centers, and pharmacy benefit management activities. Complementary services are offered to corporate clients and public institutions through medication management contracts and clinical service agreements.
Relevant market factors include rising healthcare costs, competition from retail chains and digital platforms, federal and state regulatory frameworks, drug pricing dynamics, consolidation within the integrated healthcare sector, and technological advancements in remote care and patient management.
Corporate scale is represented by thousands of retail locations, millions of members served through pharmacy benefit plans, and extensive clinical and administrative infrastructure throughout the United States.
The operational structure consists of an integrated model comprising pharmacies, medical clinics, distribution centers, pharmacy benefit management units, and digital care platforms. The corporate headquarters is located in Woonsocket, Rhode Island, with divisions dedicated to retail, healthcare services, pharmacy benefits management, and clinical operations.
The operating model combines retail pharmacy, clinical service delivery, medication therapy management, logistics and distribution, and corporate healthcare solutions. Key processes include technological integration, regulatory compliance, multichannel service delivery, and coordinated medical care.
The principal trading ticker for CVS Health Corporation is CVS, listed on the New York Stock Exchange (NYSE).
History and Foundation
Founded in 1963 in Lowell, Massachusetts, as a health and beauty products store, the operation later expanded into pharmaceutical services.During its early years, challenges included regional expansion, the shift toward a large-scale pharmacy model, and the integration of newly acquired units. Key achievements involved expanding the retail network and strengthening its position in the U.S. pharmacy market.
Expansion and growth occurred through entry into the pharmacy benefits segment, acquisitions of regional chains, development of clinical services, and the broadening of its integrated healthcare operations. Progress included investments in technology, clinic networks, and strategic partnerships.
Major historical milestones include the 1969 initial public offering (IPO), the acquisition of Caremark in 2007, the subsequent integration of clinical units, and the acquisition of Aetna in 2018, which consolidated operations across health insurance, retail, and pharmacy benefit management.
Between 2020 and 2024, developments included modernization of digital platforms, expansion of telemedicine services, operational adjustments in retail units, clinical integration initiatives, and impacts from regulatory changes and fluctuations in healthcare and drug costs in the United States.
Additional Information
The Company CVS Health Corporation (United States), is listed on NYSE with a market value of $ 101.68 Billions, having an equity of $ 73.11 Billions.
With a total of 202.000 employees, the company is listed in the sector of Health and categorized in industry of Health Services and Providers.
In the last 12 months the Company had a revenue of $ 394.08 Billions, which generated a loss in the amount of $ 469.00 Millions.
As for its main indicators, the Company has a P/E ratio of 216.81, a P/BV ratio of 1.39 and in the last 12 months the dividend yield of CVS was at 3.32%.
The Company is traded internationally through the ticker CVS.